Cresset will be sponsoring and contributing to the agenda at AI in Drug Discovery 2026. As part of our commitment to advancing innovation in drug discovery, we’ll be sharing insights, showcasing our expertise, and engaging with the community throughout the event. Visit us at booth 3!

Don’t miss Mark Mackey, Cresset’s Chief Scientific Officer, presenting “Smarter, Faster Designs: Using AI/ML to Prioritize the Molecules That Matter” at 5 pm on day 1.

In this forward‑looking session, Mark will reveal how Cresset is transforming molecular discovery through cutting‑edge computational science, including:

• Accelerated design decisions – Discover how combining FEP calculations with AI/ML enables rapid, accurate prediction of on‑target activity across vast design spaces.
• Digital molecular discovery workflows – See how scalable, automated pipelines can identify and prioritize high‑value molecules, reduce unnecessary synthesis, and support a digital‑first discovery strategy.
• Next‑generation ADME modeling – Learn how an AI superlearner approach is outperforming traditional ADME methods, enabling confident triage and smarter allocation of experimental resources.

If you’re looking to supercharge your discovery programs with AI‑driven design, this is the session for you.